Back
Neurogene Quote, Financials, Valuation and Earnings
Sponsored
NGNE
Sponsored
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
5
NGNE
Neurogene
Last Price:
40.09
Seasonality Move:
50.43%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereNeurogene Price Quote
$40.09
+0.55 (+1.39%)
(Updated: November 14, 2024 at 11:15 AM ET)
Neurogene Key Stats
Sell
5
Neurogene (NGNE)
is a Sell
Day range:
$39.08 - $41.33
52-week range:
$12.49 - $74.49
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.35%
Volume:
588.4K
Avg. volume:
250.8K
1-year change:
194.2%
Market cap:
$519.7M
Revenue:
$0
EPS:
$-20.01
How Much Does Neurogene Make?
Data Unavailable
Is Neurogene Growing As A Company?
Data Unavailable
Neurogene Stock Price Performance
What Is Neurogene 52-Week High & Low?
Neurogene Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Neurogene?
Is Neurogene Cash Flow Positive?
Neurogene Return On Invested Capital
Data Unavailable
Neurogene Earnings Date & Stock Price
-
What Is Neurogene's Stock Price Today?
A single share of NGNE can be purchased today for 39.54 -
What Is Neurogene’s Stock Symbol?
Neurogene trades on the nasdaq under the ticker symbol: NGNE -
When Is Neurogene’s Next Earnings Date?
The next quarterly earnings date for Neurogene is scheduled on November 29, 2024 -
When Is NGNE's next ex-dividend date?
Neurogene's next ex-dividend date is November 14, 2024 -
How To Buy Neurogene Stock?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Neurogene Competitors
Neurogene Dividend Yield
-
What Is NGNE Dividend Yield?
Neurogene’s dividend yield currently is 0% -
What Is Neurogene’s Payout Ratio?
Neurogene’s payout ratio is 0% -
When Did Neurogene Last Pay A Dividend?
The latest dividend pay date is November 14, 2024 -
What Is Neurogene’s Dividend Per Share?
Neurogene pays a dividend of $0.00 per share
Neurogene Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 57.20 |
Upside from Last Price: | 44.66% |